Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,209
Total Claims
$796K
Drug Cost
437
Beneficiaries
$1,821
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+121%
Opioid rate vs peers
5.7% vs 2.6% avg
+71%
Cost per patient vs peers
$1,821 vs $1,068 avg
+91%
Brand preference vs peers
17.2% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
5.7%
Opioid Rate
1,039
Opioid Claims
$16K
Opioid Cost
2.9%
Long-Acting Rate
Brand vs Generic
Brand: 3,133 claims · $527K
Generic: 15,064 claims · $268K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 552 | $95K |
| Insulin Glargine,hum.Rec.Anlog | 109 | $43K |
| Fluticasone/Umeclidin/Vilanter | 47 | $32K |
| Insulin Glargine,hum.Rec.Anlog | 146 | $24K |
| Dulaglutide | 85 | $24K |
| Semaglutide | 21 | $21K |
| Fluticasone/Vilanterol | 70 | $18K |
| Insulin Aspart | 42 | $17K |
| Rivaroxaban | 104 | $17K |
| Sitagliptin Phosphate | 92 | $16K |
| Empagliflozin | 56 | $12K |
| Rifaximin | 14 | $12K |
| Atorvastatin Calcium | 955 | $12K |
| Cariprazine Hcl | 20 | $11K |
| Potassium Chloride | 719 | $11K |
Prescribing Profile
Patient Profile
78
Avg Age
63%
Female
2.40
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data